Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double trigger GnRH agonist plus recombinant hCG for intrauterine insemination
IRCT20240514061800N6Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of recombinant human chorionic gonadotrophin in female infertility, sponsored by Shahid Beheshti University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20240514061800N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240514061800N6.